ArticleLancet regional health. Americas2023

Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study.

Affan Shoukat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.